Sectoral Funds: The pharma sector has grown at the rate of 42.52 per cent in the last one year (As per Value Research data). It is expected to continue its good performance in the coming few years.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

In such a situation, high returns can be achieved by investing strategically in pharma-based sectoral funds.

Sharekhan has selected 4 pharma sectoral funds for mutual fund investors.

Eighty per cent of these funds will be invested only in pharma sector companies.

However, these funds have high risks but are expected to give high returns.

Top 4 Pharma Sectoral Funds

1. Aditya Birla Sun Life Pharma & Healthcare Fund

2. Nippon India Pharma Fund 

3. Tata India Pharma And Healthcare Fund 

4. ICICI Prudential Pharma Healthcare and Diagnostics Fund

Aditya Birla Sun Life Pharma Fund

As on January 25, the NAV of Aditya Birla Sun Life Pharma Fund is Rs 26.7.

The fund size is Rs 585 crore. As much as 95.59 per cent of this fund has been invested in domestic equity.

Its one-year return is 50.14 per cent. The 1-year return for SIP investors is 33.2 per cent.

Nippon India Pharma Fund 

As on January 25, the NAV of Nippon India Pharma Fund is Rs 448.

The fund size is Rs 6470 crore. As much as 98.54 per cent of this fund has been invested in domestic equity.

The 1-year return is 48.59 per cent. The 1-year return for SIP investors is 31.13 per cent.

Tata India Pharma And Healthcare Fund

As on January 25, the NAV of Tata India & Healthcare Fund is Rs 27.

The fund size is Rs 760 crore.

A total of 97.94 per cent of this fund has been invested in domestic equity.

The 1-year return is 46.05 per cent. The 1-year return for SIP investors is 30.66 per cent.

ICICI Prudential Pharma Healthcare and Diagnostics Fund

As on January 25, the NAV of ICICI Prudential Pharma Healthcare and Diagnostic Fund is Rs 30.4.

The fund size is Rs 3360 crore.

A total of 94.75 per cent of this fund has been invested in domestic equity.

The 1-year return is 51.98 per cent. The 1-year return for SIP investors is 33.47 per cent.

(Disclaimer: These are not the views of Zee Business. Consult your advisor before investing.)